Module

Melanoma Diagnosis and Staging: Evolving Practice

Source: Melanoma Treatment Update

Melanoma Diagnosis and Staging: Evolving Practice

Program Director: John M. Kirkwood, MD

Faculty:
Jeffrey E. Gershenwald, MD, FACS

CME CREDIT INFORMATION

Release Date: 03/21/08

Expiration Date: 03/20/09

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Registered Nurses: 1.0 Nursing CE credit

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Explain the role of sentinel lymph node biopsy in the staging of melanoma
Discuss the tumor, node, metastases classifications of melanoma and the prognoses associated with the various TNM categories
Explain how subgroups in the stage III grouping differ regarding nodal involvement and prognosis
Describe new molecular profiling technologies for melanoma patients and the relationship between molecular prognostic factors and outcome

Topics covered include:

Introduction
Assessing Nodal Status: The Role of Lymphatic Mapping and SLN Biopsy
Sentinel Lymph Node Biopsy: State-of-the-Art Practice and Current Controversies
TNM Classification in Melanoma
Stage Groupings in Melanoma
Emerging Prognostic Factors
The Role of Imaging Modalities in Melanoma Diagnosis and Staging
The Role of Molecular Profiling in Melanoma
Surveillance of Patients With Melanoma

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.